OBSEF (ObsEva) EBITDA Margin %: 161.52% (As of Dec. 2022)


OBSEF ObsEva SA OBSEF
18 GF Score
Price $0.00
View Full Analysis

What is ObsEva EBITDA Margin %?

ObsEva OBSEF 18 EBITDA Margin % is 161.52% as of Dec. 2022. GuruFocus rates OBSEF with a GF Score™ of 18/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ObsEva's EBITDA for the three months ended in Dec. 2022 was $31.72 Mil. ObsEva's Revenue for the three months ended in Dec. 2022 was $19.64 Mil. Therefore, ObsEva's EBITDA margin for the quarter that ended in Dec. 2022 was 161.52%.

ObsEva  (OTCPK:OBSEF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

ObsEva EBITDA Margin % Related Terms

ObsEva EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for ObsEva's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ObsEva EBITDA Margin % Chart

ObsEva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -219.27 -102.22

ObsEva Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.64 0.00 0.00 0.00 161.52

OBSEF vs VRTX, REGN, SGEN: EBITDA Margin % Comparison

For the Biotechnology subindustry, ObsEva's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ObsEva EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ObsEva's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ObsEva's EBITDA Margin % falls into.


OBSEF
18GF Score
ObsEva SA OBSEF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ObsEva EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ObsEva's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-20.073/19.637
=-102.22 %

ObsEva's EBITDA Margin % for the quarter that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=31.717/19.637
=161.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 161.52% mean?
ObsEva (OBSEF) has a EBITDA Margin % of 161.52% as of Dec. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ObsEva and its competitors.
Is ObsEva's EBITDA Margin % too high?
ObsEva's current EBITDA Margin % is 161.52%. Overall, ObsEva has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does ObsEva's EBITDA Margin % compare to VRTX and REGN?
ObsEva's EBITDA Margin % of 161.52% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ObsEva and its competitors. ObsEva's current EBITDA Margin % is 161.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ObsEva stock overvalued right now?
ObsEva (OBSEF) has a current EBITDA Margin % of 161.52%. The current EBITDA Margin % is 161.52%. ObsEva's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ObsEva (OBSEF), the current EBITDA Margin % is 161.52% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ObsEva Business Description

Address Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
18GF Score

Get the complete analysis for OBSEF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price